Triethylamine → 6-bromo-4-(((3aS,4R,5R,6aS)-2-(2-hydroxy-2-methylpropanoyl)-4-methyloctahydrocyclopenta[c]pyrrol-5-yl)amino)pyrrolo[1,2-b]pyridazine-3-carboxamide
反応式
OC(C(F)(F)F)=O.[Br:8][C:9]1[CH:10]=[C:11]2[C:16]([NH:17][C@@H:18]3[CH2:25][C@@H:21]4[CH2:22][NH:23][CH2:24][C@@H:20]4[C@H:19]3[CH3:26])=[C:15]([C:27]([NH2:29])=[O:28])[CH:14]=[N:13][N:12]2[CH:30]=1.[OH:31][C:32]([CH3:37])([CH3:36])[C:33](O)=[O:34].C(N(CC)CC)C>CN(C)C=O.C(OCC)(=O)C>[Br:8][C:9]1[CH:10]=[C:11]2[C:16]([NH:17][C@@H:18]3[CH2:25][C@@H:21]4[CH2:22][N:23]([C:33](=[O:34])[C:32]([OH:31])([CH3:37])[CH3:36])[CH2:24][C@@H:20]4[C@H:19]3[CH3:26])=[C:15]([C:27]([NH2:29])=[O:28])[CH:14]=[N:13][N:12]2[CH:30]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of 6-bromo-4-(((3aS,4R,5R,6aS)-4-methyloctahydrocyclopenta[c]pyrrol-5-yl)amino)pyrrolo[1,2-b]pyridazine-3-carboxamide TFA salt from Step 2 of Example 59 (151 mg, 0.307 mmol), 2-hydroxy-2-methylpropanoic acid (38.3 mg, 0.368 mmol), triethylamine (0.128 mL, 0.920 mmol) and (benzotriazol-1-yloxy)tris(dimethylamine)phosphonium hexafluorophosphate (163 mg, 0.368 mmol) in dimethylformamide (2 mL) was stirred at room temperature for 2 h. The mixture was diluted with ethyl acetate (80 mL), washed with saturated sodium bicarbonate, water, brine, dried (MgSO4) and concentrated to give the expected product (120 mg). 1H NMR (400 MHz, methanol-d4) d 8.13 (s, 1H), 7.63 (d, J=1.8 Hz, 1H), 7.03 (d, J=1.8 Hz, 1H), 4.35-4.03 (m, 2H), 3.99-3.51 (m, 3H), 2.88-2.79 (m, 1H), 2.72-2.66 (m, 2H), 1.82-1.61 (m, 2H), 1.47-1.39 (m, 6H), 1.16 (d, J=6.6 Hz, 3H); MS (ES+) m/z: 436.1, 438.2 (M+H); LCMS (M+1): 464.1, 466.2.
後処理
- washwashed with saturated sodium bicarbonate, water, brine
- dry with materialdried (MgSO4)
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-15399709a9ea4515827aedfc01f698ec
- 出典データセット
- uspto-grants-2015_03
- 特許番号
- US08987268B2
反応ノート
読み込み中…